MCM
TMO icon

Murphy Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Murphy Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$430K Sell
792
-100
-11% -$55K 0.06% 153
2022
Q1 		$526K Sell
892
-15
-2% -$8.62K 0.06% 151
2021
Q4 		$605K Buy
+907
New +$566K 0.07% 150

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Murphy Capital Management's TMO Position: Q2 2022 in Review

Murphy Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2022, selling an estimated $55K and leaving 792 shares worth $430K. The position accounts for 0.06% of the portfolio, ranked #153.

Murphy Capital Management first reported a position in TMO in Q4 2021 and has held it in 3 quarters since. The position peaked at $605K in Q4 2021. 2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

  • Murphy Capital Management held 792 shares of Thermo Fisher Scientific worth $430K as of Q2 2022.
  • Murphy Capital Management sold 100 Thermo Fisher Scientific shares in Q2 2022, an estimated $55K.
  • Thermo Fisher Scientific made up 0.06% of Murphy Capital Management's portfolio in Q2 2022, its #153 holding.
  • Murphy Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 3 quarters since.
  • Murphy Capital Management's Thermo Fisher Scientific position peaked at $605K in Q4 2021.
  • 2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Murphy Capital Management's 13F filing for Q2 2022, filed 13 Jul 2022.